NEO
Neogenomics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NEO fundamentals
Neogenomics (NEO) released its earnings on Oct 28, 2025: revenue was 187.80M (YoY +11.91%), beat estimates; EPS was 0.03 (YoY -40.00%), beat estimates.
Revenue / YoY
187.80M
+11.91%
EPS / YoY
0.03
-40.00%
Report date
Oct 28, 2025
NEO Earnings Call Summary for Q3,2025
Key Takeaways:
- Revenue Momentum: 12% YoY growth driven by 24% NGS expansion and 15% clinical volume growth.
- MRD Breakthrough: RaDaR ST launch in Q1 2026 targets $30B MRD market, with pharma bookings starting Q4 2025.
- Operational Efficiency: LIMS consolidation and sales force expansion to drive 2026+ margin improvement.
- Strategic Focus: Community oncology consolidation (80%+ cancer care) and AI-driven MRD innovation.
EPS
Revenue
Revenue & Expenses
NEO has released its 2025 Q3 earnings report, with revenue of 187.80M, reflecting a YoY change of 11.90%, and net profit of -27.13M, showing a YoY change of -53.28%. The Sankey diagram below clearly presents NEO's revenue sources and cost distribution.
Key Indicators
Neogenomics (NEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Neogenomics (NEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neogenomics (NEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neogenomics (NEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neogenomics (NEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neogenomics (NEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Neogenomics’s earnings call?What guidance did Neogenomics's management provide for the next earnings period?What is Neogenomics's gross profit margin?What is Neogenomics's latest dividend and current dividend yield?What does Neogenomics do and what are its main business segments?What is the revenue and EPS growth rate for Neogenomics year over year?What is the market's earnings forecast for Neogenomics next quarter?What factors drove the changes in Neogenomics's revenue and profit?
